Accendra Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Accendra Health, Inc. (ACH) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 443 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-02-20
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-12-31 was -275.56K shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-09-30 was 53.00K shares, a 47.52% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-06-30 was 97.00K shares, a 41.21% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-03-31 was 126.00K shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2025 was 443.00 shares, a 25.14% increase from fiscal 2024.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 354.00 shares, a 41.58% decline from fiscal 2023.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 606.00 shares, a 99.96% decline from fiscal 2022.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 1.63M shares, a 12.29% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -275.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -222.56K shares derived: sum of 2 quarters · filed 2026-02-20 | -125.56K shares derived: sum of 3 quarters · filed 2026-02-20 | 443.00 shares 10-K · filed 2026-02-20 | |
| 2025-09-30 | 53.00K shares 10-Q · filed 2025-10-31 | 150.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 276.00K shares 10-Q · filed 2025-10-31 | -42.65K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-06-30 | 97.00K shares 10-Q · filed 2025-08-11 | 223.00K shares 10-Q · filed 2025-08-11 | -95.65K shares derived: sum of 3 quarters · filed 2026-02-20 | 5.35K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-03-31 | 126.00K shares derived: 10-K 12 month − 3 quarters · filed 2026-02-20 | -192.65K shares derived: sum of 2 quarters · filed 2026-02-20 | -91.65K shares derived: sum of 3 quarters · filed 2026-02-20 | 73.35K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-12-31 | -318.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -217.65K shares derived: sum of 2 quarters · filed 2026-02-20 | -52.65K shares derived: sum of 3 quarters · filed 2026-02-20 | 354.00 shares 10-K · filed 2026-02-20 | 573.00K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 101.00K shares 10-Q · filed 2025-10-31 | 266.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 319.00K shares 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | 165.00K shares 10-Q · filed 2025-08-11 | 218.00K shares 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | 606.00 shares 10-K · filed 2026-02-20 | 977.00K shares 10-K · filed 2024-02-20 | |||
| 2022-12-31 | 1.63M shares 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | 1.45M shares 10-K · filed 2024-02-20 | ||||
| 2020-12-31 | 501.00K shares 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | 965.00K shares 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | 809.00K shares 10-K · filed 2020-03-04 | ||||
| 2017-12-31 | 235.00K shares 10-K · filed 2019-03-06 | ||||
| 2016-12-31 | 248.00K shares 10-K · filed 2019-03-06 | ||||
| 2015-12-31 | 60.00K shares 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | 94.00K shares 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | 115.00K shares 10-K · filed 2016-02-25 | ||||
| 2012-12-31 | 104.00K shares 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | 150.00K shares 10-K · filed 2014-02-25 | ||||
| 2010-12-31 | 44.00K shares 10-K · filed 2013-02-22 | ||||
| 2009-12-31 | 28.00K shares 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |